Synthesis of hybrid 4-anilinoquinoline triazines as potent antimalarial agents, their in silico modeling and bioevaluation as Plasmodium falciparumtransketolase and β-hematin inhibitors

Analogues of a novel class of hybrid 4-anilinoquinoline triazines have been synthesized with the aim of identifying the compounds with improved antimalarial activity preserving the potency of parent drug chloroquine (CQ). All the synthesized molecules were evaluated in vitro for their antimalarial activity against chloroquine-sensitive 3D7 and chloroquine-resistant K1 strains of P. falciparum. Molecules were also screened for their cytotoxicity towards VERO cell line. Sixteen compounds (17, 19, 26, 27, 29, 31, 32, 33, 35, 36, 37, 39, 40, 49, 50, and 52) exhibited excellent antimalarial activity with IC50 values ranging from 1.36–4.63 ng ml−1 and were also found to be nontoxic with good selectivity index. In silico activity prediction as well as enzyme inhibitory activity against P. falciparumtransketolase reveals that the molecules are also good inhibitors of the enzymeP. falciparumtransketolase. The compound 52 showed good in vivo activity by oral route and resulted in survival of 3 out of 5 mice till day 28.

[1]  S. Meshnick,et al.  Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand Border , 2008, Emerging infectious diseases.

[2]  Jochen Wiesner,et al.  New antimalarial drugs. , 2003, Angewandte Chemie.

[3]  R. D. Williams,et al.  Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. , 1997, Cancer research.

[4]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[5]  W. Peters,et al.  The chemotherapy of rodent malaria. XLII. Halofantrine and halofantrine resistance. , 1987, Annals of tropical medicine and parasitology.

[6]  Shikha S. Chauhan,et al.  Trioxaquines: hybrid molecules for the treatment of malaria. , 2010, Drug news & perspectives.

[7]  Ashok Kumar,et al.  4-anilinoquinoline triazines: a novel class of hybrid antimalarial agents. , 2011, European journal of medicinal chemistry.

[8]  James R. Brown,et al.  Thousands of chemical starting points for antimalarial lead identification , 2010, Nature.

[9]  Virander S. Chauhan,et al.  Assay of β-hematin formation by malaria parasite , 1999 .

[10]  M. D. de Souza,et al.  Synthesis, Antimalarial Activity, and Intracellular Targets of MEFAS, a New Hybrid Compound Derived from Mefloquine and Artesunate , 2008, Antimicrobial Agents and Chemotherapy.

[11]  H. Ranson,et al.  Transcription profiling of a recently colonised pyrethroid resistant Anopheles gambiae strain from Ghana , 2007, BMC Genomics.

[12]  Marwa Ali-Tammam,et al.  First case of detection of Plasmodium knowlesi in Spain by Real Time PCR in a traveller from Southeast Asia , 2010, Malaria Journal.

[13]  M. Siddiqi,et al.  Identification of potential P. falciparum transketolase inhibitors: pharmacophore design, in silico screening and docking studies , 2010 .

[14]  B. Knols,et al.  Entomopathogenic fungi as the next-generation control agents against malaria mosquitoes. , 2010, Future microbiology.

[15]  K. Silamut,et al.  Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.

[16]  T. Wellems.  Plasmodium Chloroquine Resistance and the Search for a Replacement Antimalarial Drug , 2002, Science.

[17]  M. Schlitzer,et al.  Malaria Chemotherapeutics Part I: History of Antimalarial Drug Development, Currently Used Therapeutics, and Drugs in Clinical Development , 2007, ChemMedChem.

[18]  M. Enserink.  Global public health. What's next for disease eradication? , 2010, Science.

[19]  D. Goldberg.  When the Host Is Smarter Than the Parasite , 2002, Science.

[20]  D. Krogstad,et al.  Structure-activity relationships for antiplasmodial activity among 7-substituted 4-aminoquinolines. , 1998, Journal of medicinal chemistry.

[21]  Martin Enserink,et al.  Source of New Hope Against Malaria is in Short Supply , 2005, Science.

[22]  K. Srivastava,et al.  In-vitro culture of Plasmodium falciparum: utility of modified (RPNI) medium for drug-sensitivity studies using SYBR Green I assay. , 2011, Experimental parasitology.

[23]  Anang A. Shelat,et al.  Chemical genetics of Plasmodium falciparum , 2010, Nature.

[24]  G. Schneider,et al.  Crystal structure of transketolase in complex with thiamine thiazolone diphosphate, an analogue of the reaction intermediate, at 2.3 Å resolution , 1993, FEBS letters.

[25]  P. Sagar,et al.  Acid phosphomonoesterase heterogeneity in axenically grown Entamoeba histolytica. , 1987, Annals of tropical medicine and parasitology.

[26]  H. Ginsburg,et al.  Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. , 1998, Biochemical pharmacology.

[27]  M. P. Holloway,et al.  The catalytic mechanism of transketolase. Thiamin pyrophosphate-derived transition states for transketolase and pyruvate dehydrogenase are not identical. , 1983, Journal of Biological Chemistry.

[28]  K. Srivastava,et al.  Synthesis of oxalamide and triazine derivatives as a novel class of hybrid 4-aminoquinoline with potent antiplasmodial activity. , 2009, Bioorganic & medicinal chemistry.

[29]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.

[30]  S. Burgess,et al.  A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum. , 2006, Journal of medicinal chemistry.

[31]  S. Srivastava,et al.  Present trends and future strategy in chemotherapy of malaria. , 2001, Current medicinal chemistry.

[32]  Angray S. Kang,et al.  Development of Transgenic Fungi That Kill Human Malaria Parasites in Mosquitoes , 2011, Science.

[33]  Jeffrey D. Sachs,et al.  A New Global Effort to Control Malaria , 2002, Science.

[34]  A F Slater,et al.  Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. , 1993, Pharmacology & therapeutics.

[35]  S. Ward,et al.  A Requiem for Chloroquine , 2002, Science.

[36]  Peter W. Stephens,et al.  The structure of malaria pigment β-haematin , 2000, Nature.

[37]  C. D. Fitch,et al.  Ferriprotoporphyrin IX binding substances and the mode of action of chloroquine against malaria. , 1982, Life sciences.

[38]  H. Ginsburg,et al.  An integrated model of chloroquine action. , 1999, Parasitology today.

[39]  D. Goldberg,et al.  A Common Mechanism for Blockade of Heme Polymerization by Antimalarial Quinolines* , 1998, The Journal of Biological Chemistry.

[40]  M Cascante,et al.  The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study. , 2001, European journal of biochemistry.

[41]  O. Solovjeva,et al.  Inhibition of transketolase by p‐hydroxyphenylpyruvate , 1999, FEBS letters.

[42]  B. Meunier,et al.  In Vitro Activities of DU-1102, a New Trioxaquine Derivative, against Plasmodium falciparum Isolates , 2001, Antimicrobial Agents and Chemotherapy.

[43]  H. Vial,et al.  A Class of Potent Antimalarials and Their Specific Accumulation in Infected Erythrocytes , 2002, Science.

[44]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[45]  Leena Gupta,et al.  Synthesis of 2-[3-(7-Chloro-quinolin-4-ylamino)-alkyl]-1-(substituted phenyl)-2,3,4,9-tetrahydro-1H-beta-carbolines as a new class of antimalarial agents. , 2008, Bioorganic & medicinal chemistry letters.

[46]  J. E. Hyde,et al.  Drug‐resistant malaria − an insight , 2007, The FEBS journal.

[47]  A. Janowsky,et al.  Discovery of dual function acridones as a new antimalarial chemotype , 2009, Nature.

[48]  M. Enserink.  Malaria's drug miracle in danger. , 2010, Science.

[49]  Robert G. Ridley,et al.  Medical need, scientific opportunity and the drive for antimalarial drugs , 2002, Nature.

[50]  B. Meunier,et al.  Hybrid molecules with a dual mode of action: dream or reality? , 2008, Accounts of chemical research.

[51]  S. Puri,et al.  Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys. , 2000, Experimental parasitology.

[52]  David A. Fidock,et al.  Chloroquine Resistance in Plasmodium falciparum Malaria Parasites Conferred by pfcrt Mutations , 2002, Science.

[53]  K. Srivastava,et al.  Synthesis of novel thiourea, thiazolidinedione and thioparabanic acid derivatives of 4-aminoquinoline as potent antimalarials. , 2009, Bioorganic & medicinal chemistry letters.

[54]  P. Winstanley.  Chemotherapy for falciparum malaria: the armoury, the problems and the prospects. , 2000, Parasitology today.

[55]  B. Meunier,et al.  Preparation and Antimalarial Activities of “Trioxaquines”, New Modular Molecules with a Trioxane Skeleton Linked to a 4‐Aminoquinoline , 2000, Chembiochem : a European journal of chemical biology.

[56]  W. Milhous,et al.  New chimeric antimalarials with 4-aminoquinoline moiety linked to a tetraoxane skeleton. , 2008, Journal of Medicinal Chemistry.

[57]  Ashutosh Kumar,et al.  Molecular cloning and characterization of Plasmodium falciparum transketolase. , 2008, Molecular and biochemical parasitology.

[58]  David A. Fidock,et al.  Drug discovery: Priming the antimalarial pipeline , 2010, Nature.

[59]  K. Srivastava,et al.  Synthesis of new 4-aminoquinolines and quinoline-acridine hybrids as antimalarial agents. , 2010, Bioorganic & medicinal chemistry letters.

[60]  M. Foley,et al.  Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. , 1998, Pharmacology & therapeutics.